Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: A national database analysis

A significant proportion of patients on the HT waiting list will have VA. WCD use in our study showed high compliance and efficacy and a low complication rate, suggesting that the WCD is a reasonable bridge therapy for preventing SCD in patients awaiting HT.